Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02016378 · ClinicalTrials.gov registry record · Phase 3

EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents

A Phase 3 study, sponsored by University of Michigan.

Completed
Registry status
Phase 3
Development phase
25
Enrollment target

NCT02016378 is a Phase 3 study that has completed, run by University of Michigan. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02016378, a Phase 3 study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 3
Development phase
25 participants
Enrollment target

Study Summary

This study investigates the effect of a computerized approach/avoidance retraining (aka cognitive bias modification) over and above treatment as usual for patients in treatment for substance use disorders. The computerized training entails viewing pictures of drug and non-drug related stimuli, and then using the computer to make the drug pictures smaller and the non-drug pictures larger. Participants will also take part in an EEG/event-related brain potential assessment at the beginning and end of treatment to identify brain measures that are associated with treatment response.

Interventions

  • BEHAVIORAL Bias retraining
  • BEHAVIORAL Sham retraining

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2014-01
Est. Completion 2022-12
Phase Phase 3

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02016378

The ClinicalTrials.gov registry entry for NCT02016378 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Bias retraining is the first listed.

NCT02016378 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02016378 about?

NCT02016378 is a clinical study titled "EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents". This study investigates the effect of a computerized approach/avoidance retraining (aka cognitive bias modification) over and above treatment as usual for patients in treatment for substance use disorders. The computerized training entails viewing pictures of drug and non-drug related stimuli, and t...

What is the current status of trial NCT02016378?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2014-01. Estimated completion is 2022-12.

What interventions are being tested in trial NCT02016378?

The interventions under investigation include: Bias retraining (BEHAVIORAL), Sham retraining (BEHAVIORAL).

Who is sponsoring clinical trial NCT02016378?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.